| Ident. | Authors (with country if any) | Title |
|---|
| 000012 (2017) |
Aruz Mesci [Canada] ; Xiaoyong Huang [Canada] ; Samira Taeb [Canada] ; Sahar Jahangiri [Canada] ; Yohan Kim [Canada] ; Emmanouil Fokas [Royaume-Uni] ; Jeff Bruce [Canada] ; Hon S. Leong [Canada] ; Stanley K. Liu [Canada] | Targeting of CCBE1 by miR-330-3p in human breast cancer promotes metastasis |
| 000018 (2017) |
Sr Narahari [Inde] ; Madhur Guruprasad Aggithaya [Inde] ; Liselotte Thernoe [Danemark] ; Ks Bose [Inde] ; Tj Ryan [Royaume-Uni] | Response to comment on the article, “Yoga protocol for treatment of breast cancer-related lymphedema” |
| 000024 (2017) |
Ania Syrowatka ; Aude Motulsky ; Siyana Kurteva ; James A. Hanley ; William G. Dixon [Royaume-Uni] ; Ari N. Meguerditchian ; Robyn Tamblyn | Predictors of distress in female breast cancer survivors: a systematic review |
| 000030 (2017) |
Esther Jennifer Campbell ; Laszlo Romics [Royaume-Uni] | Oncological safety and cosmetic outcomes in oncoplastic breast conservation surgery, a review of the best level of evidence literature |
| 000033 (2017) |
Gurdeep S. Mannu [Royaume-Uni] ; David Dodwell [Royaume-Uni] | Making progress in early breast cancer: Taking time or accepting risk? |
| 000034 (2017) |
Marco Borri [Royaume-Uni] ; Kristiana D. Gordon [Royaume-Uni] ; Julie C. Hughes [Royaume-Uni] ; Erica D. Scurr [Royaume-Uni] ; Dow-Mu Koh [Royaume-Uni] ; Martin O. Leach [Royaume-Uni] ; Peter S. Mortimer [Royaume-Uni] ; Maria A. Schmidt [Royaume-Uni] | Magnetic Resonance Imaging–Based Assessment of Breast Cancer–Related Lymphoedema Tissue Composition |
| 000048 (2017) |
Ke Li [République populaire de Chine] ; Liang Xia [République populaire de Chine] ; Ning Fei Liu [République populaire de Chine] ; Fabio Nicoli [Royaume-Uni] ; Joannis Constantinides [Royaume-Uni] ; Christopher D'Ambrosia [États-Unis] ; Davide Lazzeri [Italie] ; Mathias Tremp [Suisse] ; Ju Fang Zhang [République populaire de Chine] ; Yi Xin Zhang [République populaire de Chine] | Far infrared ray (FIR) therapy: An effective and oncological safe treatment modality for breast cancer related lymphedema. |
| 000056 (2017) |
Sarah A. Mclaughlin [États-Unis] ; Alicia C. Staley [États-Unis] ; Frank Vicini [États-Unis] ; Paul Thiruchelvam [Royaume-Uni] ; Nancy A. Hutchison [États-Unis] ; Jane Mendez [États-Unis] ; Fiona Macneill [Royaume-Uni] ; Stanley G. Rockson [États-Unis] ; Sarah M. Desnyder [États-Unis] ; Suzanne Klimberg [États-Unis] ; Michael Alatriste [États-Unis] ; Francesco Boccardo [Italie] ; Mark L. Smith [États-Unis] ; Sheldon M. Feldman [États-Unis] | Considerations for Clinicians in the Diagnosis, Prevention, and Treatment of Breast Cancer-Related Lymphedema: Recommendations from a Multidisciplinary Expert ASBrS Panel : Part 1: Definitions, Assessments, Education, and Future Directions. |
| 000057 (2017) |
Sarah A. Mclaughlin [États-Unis] ; Sarah M. Desnyder [États-Unis] ; Suzanne Klimberg [États-Unis] ; Michael Alatriste [États-Unis] ; Francesco Boccardo [Italie] ; Mark L. Smith [États-Unis] ; Alicia C. Staley [États-Unis] ; Paul T R. Thiruchelvam [Royaume-Uni] ; Nancy A. Hutchison [États-Unis] ; Jane Mendez [États-Unis] ; Fiona Macneill [Royaume-Uni] ; Frank Vicini [États-Unis] ; Stanley G. Rockson [États-Unis] ; Sheldon M. Feldman [États-Unis] | Considerations for Clinicians in the Diagnosis, Prevention, and Treatment of Breast Cancer-Related Lymphedema, Recommendations from an Expert Panel: Part 2: Preventive and Therapeutic Options. |
| 000071 (2017) |
Helena Carreira ; Rachael Williams [Royaume-Uni] ; Martin Müller [Suisse] ; Rhea Harewood ; Krishnan Bhaskaran | Adverse mental health outcomes in breast cancer survivors compared to women who did not have cancer: systematic review protocol |
| 000074 (2017) |
David Cameron [Royaume-Uni] ; James P. Morden [Royaume-Uni] ; Peter Canney [Royaume-Uni] ; Galina Velikova [Royaume-Uni] ; Robert Coleman [Royaume-Uni] ; John Bartlett [Canada] ; Rajiv Agrawal [Royaume-Uni] ; Jane Banerji [Royaume-Uni] ; Gianfilippo Bertelli [Royaume-Uni] ; David Bloomfield [Royaume-Uni] ; A Murray Brunt [Royaume-Uni] ; Helena Earl [Royaume-Uni] ; Paul Ellis [Royaume-Uni] ; Claire Gaunt [Royaume-Uni] ; Alexa Gillman [Royaume-Uni] ; Nicholas Hearfield [Royaume-Uni] ; Robert Laing [Royaume-Uni] ; Nicholas Murray [Royaume-Uni] ; Niki Couper [Royaume-Uni] ; Robert C. Stein [Royaume-Uni] ; Mark Verrill [Royaume-Uni] ; Andrew Wardley [Royaume-Uni] ; Peter Barrett-Lee [Royaume-Uni] ; Judith M. Bliss [Royaume-Uni] | Accelerated versus standard epirubicin followed by cyclophosphamide, methotrexate, and fluorouracil or capecitabine as adjuvant therapy for breast cancer in the randomised UK TACT2 trial (CRUK/05/19): a multicentre, phase 3, open-label, randomised, controlled trial |
| 000075 (2017) |
Helena Harder [Royaume-Uni] ; Patrick Holroyd [Royaume-Uni] ; Lynn Burkinshaw [Royaume-Uni] ; Phil Watten [Royaume-Uni] ; Charles Zammit [Royaume-Uni] ; Peter R. Harris [Royaume-Uni] ; Anna Good [Royaume-Uni] ; Val Jenkins [Royaume-Uni] | A user-centred approach to developing bWell, a mobile app for arm and shoulder exercises after breast cancer treatment. |
| 000082 (2016) |
Sr Narahari [Inde] ; Madhur Guruprasad Aggithaya [Inde] ; Liselotte Thernoe [Royaume-Uni] ; Kuthaje S. Bose [Inde] ; Terence J. Ryan [Royaume-Uni] | Yoga protocol for treatment of breast cancer-related lymphedema |
| 000087 (2016) |
Judith Whatley [Royaume-Uni] ; Rachael Street [Royaume-Uni] ; Sally Kay [Royaume-Uni] ; Philip E. Harris [Royaume-Uni] | Use of reflexology in managing secondary lymphoedema for patients affected by treatments for breast cancer: A feasibility study. |
| 000089 (2016) |
Mina M G. Youssef [Royaume-Uni] ; Diane Cameron [Royaume-Uni] ; Philip H. Pucher [Royaume-Uni] ; Sisse Olsen [Royaume-Uni] ; Douglas Ferguson [Royaume-Uni] | The significance of sentinel lymph node micrometastasis in breast cancer: Comparing outcomes with and without axillary clearance. |
| 000092 (2016) |
M. Ahmed [Royaume-Uni] ; I T Rubio [Espagne] ; T. Kovacs [Royaume-Uni] ; V S Klimberg [États-Unis] ; M. Douek [Royaume-Uni] | Systematic review of axillary reverse mapping in breast cancer. |
| 000096 (2016) |
Gianpiero Manca [Royaume-Uni] ; Elisa Tardelli ; Domenico Rubello ; Marta Gennaro ; Maria Cristona Marzola ; Gary J. Cook ; Duccio Volterrani | Sentinel lymph node biopsy in breast cancer: a technical and clinical appraisal. |
| 000118 (2016) |
Hartmut Kristeleit [Royaume-Uni] ; Marina Parton [Royaume-Uni] ; Mark Beresford [Royaume-Uni] ; Iain R. Macpherson [Royaume-Uni] ; Rajan Sharma [Royaume-Uni] ; Loren Lazarus [Royaume-Uni] ; Muireann Kelleher [Royaume-Uni] | Long-term Follow-up Data from Pivotal Studies of Adjuvant Trastuzumab in Early Breast Cancer |
| 000119 (2016) |
Rohen White [Royaume-Uni] ; Tamara Dinneen [Royaume-Uni] ; Andreas Makris [Australie] | Local radiotherapy alone following neoadjuvant chemotherapy and surgery in combined clinical stage II and III breast cancer |
| 000120 (2016) |
Mirjam Cl Peek [Royaume-Uni] ; Tibor Kovacs [Royaume-Uni] ; Rose Baker [Royaume-Uni] ; Hisham Hamed [Royaume-Uni] ; Ash Kothari [Royaume-Uni] ; Michael Douek [Royaume-Uni] | Is blue dye still required during sentinel lymph node biopsy for breast cancer? |
| 000122 (2016) |
L V Coutts [Royaume-Uni] ; N R Miller [Royaume-Uni] ; Peter Mortimer (dermatologue) [Royaume-Uni] ; J C Bamber [Royaume-Uni] | Investigation of In Vivo skin stiffness anisotropy in breast cancer related lymphoedema. |
